Mitochondrial mutations are associated with a wide spectrum of human d
iseases(1,2). A common class of point mutations affects tRNA genes, an
d mutations in the tRNA-leu(UUR) gene (MTTL1) are the most frequently
detected. In earlier studies, we showed that lung carcinoma cybrid cel
ls containing high levels (greater than 95%) of mutated mtDNA from a p
atient with the pathological nucleotide pair (np) 3243 tRNA-leu(UUR) m
utation can remain genotypically stable over time, and exhibit severe
defects in mitochondrial respiratory metabolism(3,4). From such a cybr
id containing 99% mutated mtDNA, we have isolated a spontaneous deriva
tive that retains mutant mtDNA at this level but which has nevertheles
s reverted to the wild-type phenotype, based on studies of respiration
, growth in selective media, mitochondrial protein synthesis and bioge
nesis of mitochondrial membrane complexes. The cells are heteroplasmic
for a novel anticodon mutation in tRNA-leu(CUN) at np 12300, predicte
d to generate a suppressor tRNA capable of decoding UUR leucine codons
. The suppressor mutation represents approximately 10% of the total mt
DNA, but was undetectable in a muscle biopsy sample taken from the ori
ginal patient or in the parental cybrid. These results indicate that t
he primary biochemical defect in cells with high levels of np 3243 mut
ated mtDNA is the inability to translate UUR leucine codons.